Journal
PET CLINICS
Volume 13, Issue 3, Pages 339-+Publisher
ELSEVIER INC
DOI: 10.1016/j.cpet.2018.02.006
Keywords
Breast cancer therapy; Local therapy; Adjuvant therapy; Breast-conserving therapy; Mastectomy; Neoadjuvant chemotherapy; Breast cancer surveillance; Endocrine therapy
Funding
- Roche
- Genentech
- PUMA
- NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Breast cancer treatment is multidisciplinary. Most women with early-stage breast cancer are candidates for breast-conserving surgery with radiotherapy or mastectomy. The risk of local recurrence and the chance of survival do not differ with these approaches. Sentinel node biopsy is used for axillary staging, and individualized approaches are minimizing the need for axillary dissection in women with positive sentinel nodes. Adjuvant systemic therapy is used in most women based on proven survival benefit, and molecular profiling to individualize treatment based on risk is now a clinical reality for patients with hormone receptor-positive cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available